Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy
about
St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell deathUnique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiationHigh-throughput screen of natural product libraries for hsp90 inhibitors.BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression.Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line.Small-molecule inhibitors of the HIF pathway and synthetic lethal interactions.A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells.Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target.Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.Mitochondrial stress-induced p53 attenuates HIF-1α activity by physical association and enhanced ubiquitination.Interaction of HIF-1α and Notch3 Is Required for the Expression of Carbonic Anhydrase 9 in Breast Carcinoma Cells.Discovery of Manassantin A Protein Targets Using Large-Scale Protein Folding and Stability Measurements.High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.High expression of heat shock proteins and heat shock factor-1 distinguishes an aggressive subset of clear cell renal cell carcinoma.
P2860
Q21131978-742C1598-5CA3-47FE-BF84-50F6186571CCQ28533490-941E0BE0-2A19-4F02-925F-749878BA7A5DQ35169647-89A62933-49EF-4B73-BAB0-075609FD312DQ36347256-5ADFD39C-85A4-4640-877A-CB8DE46A7AEDQ36566111-33B72EC4-C136-42AC-BA96-97434112E72FQ38003390-017FE5EC-6702-4411-A640-02449F8B24C4Q38740331-F3872DBB-CA3A-46E0-B884-DAE751922B28Q38826788-E710B963-4874-4E54-B6A8-7F8A2876D742Q39051696-16D1BCFC-BF3E-401E-A978-47DD20C8DA0AQ40030805-82CD371C-DBE8-43A9-A0DA-B1C9392F0D98Q41844894-45DA7BDE-C5F7-4373-84C5-3446905B608CQ42007543-8124D68E-0236-412A-8FCA-D423702171DAQ42098076-16E7AE0F-E6E4-49B7-9123-30BA93C86453Q47855849-2D3BCC8A-F44A-4743-9723-672A7948E6B7
P2860
Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@ast
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@en
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@nl
type
label
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@ast
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@en
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@nl
prefLabel
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@ast
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@en
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@nl
P2093
P2860
P3181
P1433
P1476
Degradation of HIF-1alpha unde ...... ricin: a unique cancer therapy
@en
P2093
Mathilda Mandel
Tami Livnat
Tilda Barliya
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0022849
P407
P577
2011-01-01T00:00:00Z